What GPs need to know about GLP-1 RAs SPONSORED: The medication has been described as a ‘paradigm shift’ in the way type 2 diabetes is managed.
New MBS items aim to help multidisciplinary care The Department of Health says the funding will help GPs work with other health disciplines to support vulnerable patients.
Progress made on Closing the Gap Latest AIHW figures show the health gap is narrowing between Aboriginal and Torres Strait Islander people and non-Indigenous Australians.
How nutrition could make a significant difference to chronic disease A new study has highlighted the clear benefits of personalised nutrition support in community-based health services, such as general practice.
engageGP previews RACGP Federal Election campaign The forum provided details on the college’s Federal Election strategy and also allowed members to highlight issues impacting general practice.
AIHW report highlights ‘vast burden’ of chronic disease Around one in two Australians over the age of 15 had a long-term health condition in 2019–20, a patient survey has revealed.
GPs expected to have ‘really important role’ in new COVID therapy Federal Health Minister Greg Hunt has said sotrovimab will be available sometime this week. But uncertainties remain about how patients will access the treatment.
Venous disease The Good GP interviews vascular surgeon Dr Samantha Peden on venous ulcers and chronic venous insufficiencies.
What is the COVID-19 treatment sotrovimab? The medication has shown promise in reducing hospitalisation and risk of death, and there is a chance it could be used in primary care. But experts warn the data is limited.
Where in Australia is chronic disease most prevalent? The AIHW has mapped the impact of the most prevalent chronic diseases, revealing the health-risk profile for socioeconomic areas.